China channel feed – Endpoints News

China channel feed

NIH-directed purge of researchers with China ties sweeps up Moffitt CEO Alan List, colleagues

6 years ago

BeiGene's BTK inhibitor fails to beat market leader Imbruvica in key head-to-head study

6 years ago

AstraZeneca joins Merck, Bristol-Myers in China's checkpoint race as regulators OK first PD-L1

6 years ago

Alphamab Oncology rounds out HKEX's second biotech IPO year with $230M raise and high local interest

6 years ago

Shaking up China's PD-(L)1 reimbursement landscape, Innovent, Eli Lilly earn coveted spot on national coverage

6 years ago

Roche shows Tecentriq/Avastin combo helps liver cancer patients live longer

6 years ago

Brii Bio backs infectious disease startup while inking deal for its lead TB drug, doubling down on antibiotics

6 years ago

In a first, FDA green-lights use of a Chinese built cancer therapy — and more are coming

6 years ago

Ahead of FDA decision on BTK drug, Amgen-partnered BeiGene is one step closer to China OK for PD-1

6 years ago

ARCH-backed Chinese biotech scores PhIII win for glucokinase-modulating diabetes drug

6 years ago

Tot Biopharm completes HKEX listing, raising $63M in modest debut

6 years ago

Alzheimer's breakthrough? Not so fast — experts poke holes in data underlying China's surprise approval

6 years ago

AstraZeneca sketches plans for a $1B venture fund — and it's going to China

6 years ago

Sino Biopharm, OrbiMed back Merck-partnered Akesobio's bet on made-in-China antibodies

6 years ago

Alzheimer's stunner: Chinese biotech wins OK for a new drug on positive data — and they have some high-profile supporters

6 years ago

Amgen takes a $2.7B stake in BeiGene, gaining a prominent ally in China to help seize a leading role in cancer drug commercialization and development

6 years ago

In a bid to get to Chinese patients faster, Shanghai's I-Mab plans $100M Nasdaq IPO

6 years ago

Ascentage soars during its first day on the Hong Kong exchange, following $53M debut

6 years ago

China's Fountain Medical scores $62M as demand for CRO services surges

6 years ago

Merck KGaA wants to get in early on Chinese innovation — so it's setting up a seed fund there

6 years ago

Following top-level C-suite departures, Ascletis raids Novartis for R&D exec

6 years ago

San Diego couple charged with stealing trade secrets, opening Chinese biotech as DOJ crackdown continues

6 years ago

Cancer drugs among US goods spared from tariffs as China issues first exemptions in trade war

6 years ago

How about a $477M biotech IPO amid Hong Kong protests? Henlius will find out

6 years ago

First page Previous page 18 19 202122 23 24 Next page Last page